A Novel Allosteric Inhibitor Targeting IMPDH at Y233 Overcomes Resistance to Tyrosine Kinase Inhibitors in LymphomaNagarajan Pattabiraman(Versar (United States)), Johnvesly Basappa(Fox Chase Cancer Center)Preprints.orgSeptember 21, 202510.20944/preprints202509.1644.v1Cited by 1SaveCiteExport RISWatch citationsRelated PapersGlyGen: Computational and Informatics Resources for Glycoscience|Glycobiology|2019|207A Novel Allosteric Inhibitor Targeting IMPDH at Y233 Overcomes Resistance to Tyrosine Kinase Inhibitors in Lymphoma|Cancers|2025|0